Company Expects to Submit Trial Results to FDA in Fourth Quarter of 2017 Redwood City, CA – October 18, 2016 – Gynesonics, a women’s healthcare company focused on the development of advanced incision-free solutions for treatment of benign uterine conditions, today announced the completion of enrollment in the SONATA Investigational Device Exemption (IDE) clinical trial, […]
Redwood City, CA – May 5, 2016 – Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that medical device executive Jiayu Chen, Ph.D., has been named Vice President of Engineering and Advanced Technologies, effective immediately. Dr. Chen reports directly to President and CEO Christopher […]
Accomplished Clinical Affairs Executive to Lead Clinical Research Initiatives and Programs Redwood City, CA – February 25, 2016 – Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that veteran clinical affairs executive Taraneh G. Farazi, Ph.D has been named Vice President, Clinical Affairs. Dr. […]
Novit Ventures LP Participates in Latest Round Redwood City, CA – November 17, 2015 – Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced $2.9 million of additional equity financing, increasing the aggregate amount raised to $46 million, completing this round of financing. Rockville, MD-based […]
Presentation on Early Clinical Response to Sonata™ System Selected as Best Abstract In New Instrumentation/Technology Category Redwood City, CA—November 12, 2015 – Gynesonics, Inc., a women’s health technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of uterine fibroids, announced today that its Sonata™ System technology […]
Designated ‘One of the Most Promising Private Med Tech Companies’ of 2014 REDWOOD CITY, CA – October 9, 2014 – Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced it has been named by FierceMedicalDevices to its 2014 Fierce 15, a designation given to […]
AMA Establishes Code for Reimbursement of the Innovative Procedure for Uterine Fibroids Redwood City, CA – August 4, 2015 – Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that the American Medical Association (AMA) Current Procedure Terminology (CPT) Editorial Panel has established a new […]
Endeavour Vision and Abingworth Lead Funding Redwood City, CA – July 22, 2015 – Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that it has raised $43 million in an equity financing. The equity financing was co-led by new investor Endeavour Vision, a technology […]
More than 100 Competitors in Medtech’s Premier Design Competition Redwood City, CA (June 30, 2015)—Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that its Sonata System was selected as the Bronze Winner in the Radiological and Electromechanical Devices Category at the 18th Annual Medical […]
FAST-EU Trial 6 Month Results Published in Gynecological Surgery; 12 Month Results presented at 43rd Annual AAGL Meeting. REDWOOD CITY, CA – December 9, 2014 – Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced the recent publication and presentation of results from the […]
